Clicky

Annovis Bio, Inc.(ANVS) News

Date Title
May 8 Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates
May 8 Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues
May 7 Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
May 6 Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
May 3 Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
May 2 Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
May 2 Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
Apr 29 Annovis Bio Shares Tumble After Drug Candidate Buntanetap for Alzheimer's Misses Efficacy Endpoint in Phase 2/3 Study
Apr 29 UPDATE 3-Annovis tumbles as Alzheimer's treatment misses in mid-stage study
Apr 29 Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease
Apr 24 Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade
Apr 23 Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
Apr 19 Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
Apr 19 Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
Apr 18 DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch
Apr 17 Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals
Apr 16 Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
Apr 16 Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
Apr 12 RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up
Apr 12 Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag